News from Covance, NIH and EMD Serono – People on the move
Outsourcing-Pharma.com presents its latest round-up of the new appointments in the pharmaceutical industry, including news from Covance, NIH and EMD Serono.
Outsourcing-Pharma.com presents its latest round-up of the new appointments in the pharmaceutical industry, including news from Covance, NIH and EMD Serono.
DSM has signed an antibody contract manufacturing deal focused in its intensified cell culture process, XD.
Bayer could spend up to 50 per cent more with Covance after it cuts ties with its other late phase CRO partner.
HHS is investing $400m (€318m) to create centres to speed development and production of medical countermeasures.